Albega Biologicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 1.99 M
- Company Age 41 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -95.19%
- Profit Growth -135.50%
- Ebitda -2.17%
- Net Worth -12.99%
- Total Assets 50.99%
About Albega Biologicals
Albega Biologicals Pvt Ltd (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 March 1983 and has a history of 41 years and 11 months. Its registered office is in Haryana, Haryana, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.99 M, as per Ministry of Corporate Affairs (MCA) records.
Sangeeta Gandhi and Rajnish Gandhi serve as directors at the Company.
Company Details
-
Location
Haryana, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U47710HR1983PTC015305
-
Company No.
015305
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Mar 1983
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Albega Biologicals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajnish Gandhi
|
Director | 20-Jul-2022 | Current |
|
Sangeeta Gandhi
|
Director | 24-Dec-2022 | Current |
Financial Performance of Albega Biologicals.
Albega Biologicals Pvt Ltd, for the financial year ended 2023, experienced significant reduction in revenue, with a 95.19% decrease. The company also saw a substantial fall in profitability, with a 135.5% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Albega Biologicals?
In 2023, Albega Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Abm International LimitedSangeeta Gandhi and Rajnish Gandhi are mutual person
-
Hermes Realbuild Private Limited
Sangeeta Gandhi and Rajnish Gandhi are mutual person
-
Prisha Hospitality LlpSangeeta Gandhi and Rajnish Gandhi are mutual person
-
Prisha Projects Llp
Sangeeta Gandhi and Rajnish Gandhi are mutual person
-
Divisha Projects Llp
Sangeeta Gandhi and Rajnish Gandhi are mutual person
-
Prisha Promoters Private Limited
Sangeeta Gandhi and Rajnish Gandhi are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Albega Biologicals?
Unlock and access historical data on people associated with Albega Biologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Albega Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albega Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
